What is the new gastric medicine? Exploring Vonoprazan and the Future of Stomach Acid Treatment
•
4 min read
Approximately 20% of people in the United States have gastroesophageal reflux disease (GERD) [1.7.1, 1.7.2]. So, what is the new gastric medicine offering hope for them? A new class of drugs called PCABs, with vonoprazan at the forefront, is changing treatment.